VisionGate's Series B Round

VisionGate raised a round of funding on June 13, 2013. Investors include GreyBird Ventures.

VisionGate is a clinical-stage oncology pharmaceutical and diagnostics company with a focus on saving lives by developing new products for the early detection, prevention and treatment of cancer, incl…

Articles about VisionGate's Series B Round: